Portugal Dental Care Market Analysis Sample Report

Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2022 – 2030F)
Portugal Dental
Care Market
Analysis
A sample report on
www.insights10.com

This report presents a strategic analysis of the Portugal Dental Care
Market and a forecast for its development in the medium and long term. It
provides a comprehensive overview of the market value, dynamics,
segmentation, main players, growth and demand drivers, challenges &
future outlook, etc. This is one of the most comprehensive reports about
the Portugal Dental Care Market, and offers unmatched value, accuracy,
and expert insights

3
A Sample Report on Portugal Dental Care Market Analysis I Confidential
Report Scope
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2022
Forecast Period 2023-2030
Report Coverage
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape,
Reimbursement Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Research Approach Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology

4
Table of Content
CONTENT PG. NO.
1. Dental Care Overview 12-25
1.1. Overview
1.2. Portugal Overview
1.3. Economic Overview: Portugal
1.4. Dental Care Market in Portugal
1.5. Healthcare Services Market in Portugal
1.6. Healthcare Scenario in Portugal
1.7. Health Insurance Coverage: Portugal
1.8. Budget of the Government for Public Insurance
1.9. Mergers and Acquisitions
2. Market Size and Forecasting 26-31
2.1 Market size and forecasts (Excel and Methodology)

5
Table of Content
CONTENT PG. NO.
2.2. Market Segmentation
2.2.1. By Product
2.2.2. By Treatment
2.2.3. By End User
3. Market Dynamics 32-36
3.1. Market Growth Drivers
3.1.1. Incidence of Dental cases is increasing in Portugal
3.1.2. Portugal has a growing tourism industry
3.1.3. Portugal's economy has been recovering since the crisis of 2008 to 2014
3.2. Market Restraints
3.2.1. Government regulations and policies may also limit the growth
3.2.2. High level of competition among dental clinics in Portugal

6
Table of Content
CONTENT PG. NO.
3.2.3. The overall economic conditions in Portugal affect dental clinics to expand
4. Competitive Landscape 37-47
4.1. Major Market Share
4.2. Key Company Profile
4.2.1. VitalDent
4.2.1.1. Overview
4.2.1.2. Product Applications & Services
4.2.1.3. Recent Developments
4.2.1.4. Partnerships Ecosystem
4.2.1.5. Financials (Based on Availability)
4.2.2. OralMED
4.2.2.1. Overview

7
Table of Content
CONTENT PG. NO.
4.2.3. Clínica de Todos os Santos
4.2.3.1. Overview
4.2.4. White Clinic
4.2.4.1. Overview

8
Table of Content
CONTENT PG. NO.
4.2.5. Dentarmed
4.2.5.1. Overview
4.2.6. DentalPro
4.2.6.1. Overview

9
Table of Content
CONTENT PG. NO.
4.2.7. Dentaurum
4.2.7.1. Overview
4.2.8. Allianz Dental
4.2.8.1. Overview

10
Table of Content
CONTENT PG. NO.
4.2.9. Dentsply Sirona
4.2.9.1. Overview
4.2.10. Malo Clinic
4.2.10.1. Overview

11
Table of Content
CONTENT PG. NO.
5. Reimbursement Scenario 48-55
5.1. Reimbursement Regulation
5.2. Reimbursement Process for Diagnosis
5.3. Reimbursement Process for Treatment
5.4 Reimbursement Process – Medicare
5.5 Reimbursement Process - Medicaid
6. Methodology & Scope 56-62

Portugal Dental Care Market Analysis
1. Dental Care Overview

13
1.1 Statistics at a Glance: The Burden of Dental Disease in the World
Prevalence of Dental Disease ▪ Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪ In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
3.5 Bn
People are estimated
to be affected by
dental diseases
3 out of 4
Are affected by some dental
diseases in middle-income
countries
19%
Of global adult population is
affected by severe periodontal
disease
82%
Socioeconomic inequalities in
access to dental care in high
income countries
2 Bn
People suffer from
dental caries in
permanent teeth
514 Mn
Children suffer from dental
caries in primary teeth

14
1.1 Statistics at a Glance: The Burden of Dental Diseases in the World
(continued)
North America
~ Market Size of
$xx Bn
Europe
~Revenue to reach
$xx Bn by 2027
Asia
-Fastest CAGR of
xx %
Africa
~Market Size of $xx
Bn
Portugal Market
~$xx Mn Market
Illustrative

15
1.2 Portugal Overview
10.27 Mn
Is the population of
Portugal, in 2022
46.8 years
Is the median age in
Portugal, in 2022
24.57 Mn
Is the Gross Domestic
Product (GDP) in
Portugal in 2021
9.5%
Was total expenditure on
health as a percentage of
GDP in Portugal in 2019
▪ Please be aware that this sample report is
report
understanding of the demographics of the
country/region, which includes the
population, GDP, healthcare expenditure
and other details related to the topic
interest

16
1.3 Economic Overview: Portugal
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
Population of Portugal, (2020-2030)
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
GDP of Portugal, (2020-2030)
Population Split (2023)
55-64
0-14
15-24
25-54
65+
Male
49%
Female
51%
By Age Group
By Gender
▪ In this section you will get an understanding of the demographics
of the country/region, which includes the population, GDP,
healthcare expenditure and other details related to the topic
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative

17
1.4 Statistics at a Glance: The Burden of Dental Diseases in Portugal
Prevalence of Dental Diseases
▪ Please be aware that this sample report
is intended to provide you with a brief
analysis that will be presented in the
final report
understanding of the topic, which
includes the prevalence of the disease,
the application of medical devices, new
technology, and other details related to
the topic in Portugal
information that you are seeking, you
will need to purchase the final report
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
$107.6 Mn
Revenue in the Oral
Care segment
amounts in Portugal
in 2022
Dental caries &
Periodontal disease
Are the most prevalent oral
diseases in Portugal
1 out of 3
Major Chronic Oral Disease is
present in almost all the adults of
Portugal
32.7%
Of Portugal population has
never visited dentist or only in
case of emergency
Dental Voucher
Strategy has been
added to the NHS
program
51.7%
People in Portugal have now
developed healthy gums in
Portugal

18
1.5 Healthcare Services in Portugal
xx xx xx xx xx xx xx xx xx
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Portugal Healthcare Services Market Forecast, 2022-2030 (in $Bn)
▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be
presented in the final report
▪ In this section you will get an understanding of the overall Healthcare Services market in Portugal, which includes the market size, current
trends and other details related to the topic
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or
Illustrative

19
1.6 Healthcare Scenario in Portugal
Dental Drug Development Process: The process of developing a cancer drug is complex and involves many stages, from preclinical research
to clinical trials to regulatory approval. Here is a simplified diagram of the cancer drug development process:
o Preclinical Research: Researchers identify potential drug candidates and test them in the lab
o Phase 1 Clinical Trials: Small studies are conducted to test the safety and dosage of the drug in humans
o Phase 2 Clinical Trials: Larger studies are conducted to test the effectiveness of the drug in treating cancer
o Phase 3 Clinical Trials: Even larger studies are conducted to compare the new drug to standard treatments and evaluate its safety and
effectiveness
o Regulatory Approval: The drug is reviewed by regulatory agencies such as the FDA and approved for use in the US market
Fast Track
▪ Fast track is a process designed to facilitate the development, and expedite the review of drugs to treat
serious conditions and fill an unmet medical need
Breakthrough
Therapy
▪ A process designed to expedite the development and review of drugs which may demonstrate substantial
improvement over available therapy
Accelerated
Approval
▪ These regulations allowed drugs for serious conditions that filled an unmet medical need to be approved
based on a surrogate endpoint
Priority Review ▪ A Priority Review designation means FDA’s goal is to take action on an application within 6 months
FDA has developed several approaches to making drugs available as quickly as possible, while still ensuring their safety and
effectiveness. Here are four of these approaches:
Illustrative

20
1.6 Healthcare Scenario: Dental Patient Journey
Appointment
Once patient have chosen a
dentist, you can call their
office or use their online
booking system to schedule
an appointment. Some
dental clinics also accept
walk-in patients, although it
is generally advisable to
make an appointment in
advance
At patient’s first visit, patient will
have an initial consultation with the
dentist. They will review patient’s
dental and medical history, discuss
any concerns or symptoms patient
may have, and perform a
comprehensive oral examination.
X-rays or other diagnostic tests
may also be recommended to
assess your oral health
Initial Consultation Treatment Planning
Based on the examination and any
additional tests, the dentist will
develop a treatment plan tailored to
your specific needs. They will
explain the recommended
procedures, their benefits, and any
potential risks involved. They will
also provide an estimate of the
costs involved and discuss
payment options
Once the treatment plan is agreed
upon, patient can schedule the
necessary appointments for the
procedures. This may include
routine cleanings, fillings, root
canals, extractions, or more
extensive treatments like dental
implants or orthodontic procedures.
Scheduling Treatment Follow-up & Maintenance
After completing the treatment, the
dentist will schedule follow-up visits
to monitor your progress and
ensure proper healing. Regular
check-ups and cleanings are
essential to maintain good oral
health. Patient’s dentist may
recommend a schedule for routine
visits based on his/her individual
needs
In Portugal, dental care may be covered partially or fully by private dental
insurance plans or public health services, such as the National Health
Service (Serviço Nacional de Saúde). If you have dental insurance, you
should check the coverage details and reimbursement procedures with
your provider. If you are paying out-of-pocket, you will need to settle the
fees directly with the dental clinic, either per visit or as agreed upon.
Dental Insurance and Payment

21
1.7 Health Insurance Coverage: Portugal
Illustrative
Healthcare in Portugal:
▪ Portugal has both public and private medical healthcare. Hospitals, medical centers, and other institutions are usually either public or
private not both
▪ Life expectancy in Portugal is around 81 years (higher than the EU average)
▪ The Portuguese government spends less on public healthcare than other European countries, and out-of-pocket expenses have been
increasing
▪ Smoking, drinking, and obesity are the biggest causes of health issues in Portugal
▪ Cardiovascular diseases and cancer are the most worrisome health concerns in the country
Public Insurance Cover in Portugal:
▪ Public healthcare system (Serviço Nacional de Saúde- SNS) in Portugal covers most of the medical needs, which include hospital
stays, doctor consultations, preventative care, diagnosis and treatment of emergency and non-emergency cases
▪ It usually does not provide coverage for dental care and cosmetic surgery. This includes preventive care, diagnosis and treatment of
both emergency and nonurgent conditions.
▪ For any services not included, you can buy a private insurance policy to include those services as well or pay for the services out of
pocket

22
Public Health Insurance for Expats in Portugal
▪ Public healthcare is managed by the National Healthcare System (Serviço Nacional de Saúde- SNS), which is generally funded by
taxation and social contributions. Those who are not employed, i.e., children and retirees, do not have to pay contributions
▪ The SNS system in Portugal is loosely based on the NHS in the UK, and it offers unrestricted access to healthcare services for all
residents. If you’re an expat working and living in Portugal, you also benefit from the SNS
▪ Under the SNS you can seek care in any of the following medical centres:
o Health centres groups (agrupamentos de centros de saúde- ACES): These healthcare centres provide primary healthcare for
local regions. Each municipality has at least one healthcare centre, which might have additional extensions
o Hospital centres (centro hospitalar): Hospital centres usually include general, district, central, or specialised hospitals, i.e.,
oncologic or psychiatric centres. This is where secondary care is administered
o Local health units (unidades locais de saúde- ULS): These are usually joint administrations of health centre groups and hospitals
within one city or region. Here both primary and secondary care is administered

23
1.0
18.9
18.4
35.7
2.5
3.5
10.2
54.3
66.0
91.7
8.3
VA and CHAMPVA
Medicaid
Medicare
Any public plan
TRICARE
Marketplace
Direct-purchase
Employment-based
Any private plan
With health insurance
Uninsured
▪ In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire calendar year
▪ More people had private health insurance (66%) than public coverage (35.7%)
▪ Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Medicaid
(18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%)
Coverage Type 2020 2021 Change %
Total 327,521 328,074
Any health plan 299,230 300,887 0.4
Any private plan 217,896 216,366 –0.6
Employment-based 178,737 178,285 –0.2
Direct-purchase 33,869 33,555 –0.1
Marketplace coverage 10,924 11,389 0.1
TRICARE 9,165 8,299 –0.3
Any public plan 112,925 117,095 1.2
Medicare 58,541 60,226 0.5
Medicaid 58,778 61,940 0.9
VA and CHAMPVA 2,967 3,151 0.1
Uninsured 28,291 27,187 –0.4
% of People by Type of Health Insurance Coverage
(2021)
Number of People By Health Insurance Coverage
Illustrative

24
1.8 Budget of Portugal Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31
In Billions Of Dollars
Medicare $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
Medicaid $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926
As % Of GDP
Medicare 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
Medicaid 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4%
▪ National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪ Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE
▪ Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE
▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE
▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE
▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE
▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020
▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020
▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020
▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health
spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative

25
1.9 Mergers and Acquisitions
$6.0
$7.7
$10.5
$16.7
$6.8
$11.7
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
82
112 107 107
89
110
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020
RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend
Buyer Composition: Strategic Vs Financial (2020)
59%
41% 41%
59% 58%
42%
61%
39%
$0- $25 $25-$50 $50-$100 $100+
Strategic Buyers
Financial Buyers
Buyer Type by Deal Size
($Mn)
Illustrative

26
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Acquisition -
January
2021
▪ OralMED Saúde, the owner of dental clinics OralMED Medicina
Dentária, acquired the entirety of the social capital of Grupo
Médico dos Dentes, becoming the only shareholder
▪ This acquisition is part of OralMED´s growth strategy
▪ The nine clinics will be incorporated to the Portuguese group,
which will own a total of 60 clinics in the country
▪ The employees of Grupo Médico dos Dentes, around 50 people,
will join the team of more than 1,000 individuals who already work
at Grupo OralMED Saúde
Latest Deals In Portugal

27
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Merger March 2023
Merger Jan 2023
Latest Deals In Portugal

2. Market Size and Forecasting

29
2.1 Market size and forecasts (Excel and Methodology)
XX
XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Portugal Dental Care Service Market Forecast, 2022-2030 (in $Bn)
final report
understanding of the overall Healthcare
Insurance market in Malaysia, which
includes the market size, current trends
and other details related to the topic
Click on the icon to know the
methodology and assumption
2023 2024 2025 2026 2027 2028 2029 2030
Major Markets Patient
(Mn)
2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Portugal Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of US Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937
Portugal Market Size (Bn
$)
61 74 84 87 91 95 99 106
Illustrative

30
2.2 Snapshot of Dental Care Market Segmentation
▪ In this section you will get an understanding of the segmentations which will cover the Portugal Dental Care Market
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Product
General and Diagnostic
Equipment
Dental Consumables
Other Dental Devices
Treatment
Orthodontic
Endodontic
Periodontic
Prosthodontic
End User
Hospitals
Dental Clinics
Other End Users

31
Portugal Dental Care Market Share, By Product (2022)
General and
Diagnostic
Equipment,
Dental
Consumables,
Other Dental
Devices,
▪ General and diagnostic equipment
market in Portugal is a significant
component of the overall dental care
market
▪ It has the maximum market share in
India dental care market with
approximately xx%
final report
2.2.1 Market Segmentation: By Product

32
Portugal Dental Care Market Share, By Treatment (2022)
Orthodontic,
Endodontic,
Periodontic,
Prosthodontic,
2.2.2 Market Segmentation: By Treatment
▪ Orthodontic market in Portugal is a
significant component of the overall
dental care market
▪ It has the maximum market share in
India dental care market with
approximately xx%
final report

33
Portugal Dental Care Market Share, By End User (2022)
Hospitals
Dental Clinics
Other End Users
2.2.3 Market Segmentation: By End User
▪ Hospitals have the maximum market
share in Portugal dental care market
with approximately xx%
final report

3. Market Dynamics

35
3.1 Market growth drivers
▪ Trends of Dental Care is increasing in Portugal, with more than 1.8 Mn
new cancer cases expected to be diagnosed in 2023
▪ This is driving the demand for dental care treatments and creating
opportunities for growth in the cancer market
▪ Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪ In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
2010 2022 2030
3.1.1 32.5% of the population and 70.6% of people older than 65 years of age had lost more than six permanent teeth,
not including third molars
Trends of Dental Care in Portugal
Illustrative

36
3.1 Market growth drivers (continued)
3.1.2 In 2021, the average age of the Portuguese population was 45.8 years. The European Union is getting older. In
2021, the average age was 44.1 years, which compares with the average of 43.9 found the previous year.
▪ Portugal, like many other European countries, has an aging
population
▪ With advancing age, there is often an increased need for
dental treatments and procedures, such as dental implants,
dentures, and periodontal care
▪ Aging population contributes to the expansion of the dental
care market
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative
2010 2022 2030
Aging population of Portugal

37
3.1 Market growth drivers (continued)
3.1.2 Portugal has emerged as a popular destination for dental tourism in recent years. Dental tourism refers to
traveling to another country to receive dental treatment at lower costs or to access specialized services that may not
be available or affordable in one's home country
▪ Portugal has become a popular dental tourism destination due
to its high-quality dental services, affordable prices compared to
some other European countries, and the country's attractive
tourism offerings
▪ Dental care provided in Portugal meets high standards of quality
and professionalism
▪ Portuguese dentists are well-trained, often with international
education and experience, and dental clinics are equipped with
modern technology and adhere to strict hygiene standards
▪ Portugal's geographical location in southwestern Europe makes
it easily accessible for dental tourists from other European
countries.
▪ Country has well-connected airports and a developed tourism
infrastructure, providing convenience for international patients.
▪ Dental tourism drives the dental care market by attracting
patients from abroad who seek dental treatments while enjoying
a vacation
Illustrative
2010 2022 2030
Medical Tourism in Portugal

38
3.2 Market restraints
3.2.1 Economic conditions
can influence the dental care
market.
▪ During periods of economic
downturn or instability,
individuals may postpone or
reduce their spending on non-
essential healthcare services,
including dental treatments
▪ Financial constraints can limit
access to dental care and affect
the demand for certain
procedures
3.2.2 The public funding for dental
care in Portugal is generally
limited
▪ While some dental services may
be covered by the National
Health Service (Serviço Nacional
de Saúde), the coverage is often
restricted, and there may be long
waiting times for treatments
▪ This limitation in public funding
can result in a higher reliance on
private dental care, which may
not be affordable for everyone.
3.2.3 There can be regional
disparities in the distribution of
dental professionals across
Portugal
▪ Some areas, particularly rural or
remote regions, may have limited
access to dental services due to
a shortage of dentists. This can
create challenges in providing
timely and accessible dental care
to all segments of the population.
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative

4. Competitive Landscape

40
4.1 Major Market Share
XX
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
▪ Portugal Dental Care market is a highly
competitive space, with many companies
developing and marketing cancer
treatments
▪ Some of the top companies in Portugal
Dental Care market based on revenue and
market share include
interest
Revenue of Major players in Portugal Dental Care
Market ($ Mn)
Illustrative

41
4.2 Key Company Profile
▪ Here is the list of top 10 companies which
will cover in the final report
▪ Each company will have slides for
o Overview
o Key details
o Offerings
o Name of products
o Recent activities/ Press Coverage
o Distribution and Vendor Partners
o Mergers, Acquisitions and
Collaboration
o Financials
▪ If there are specific companies that you
would like to be included in the report,
please let us know via email
1 Vital Dent
3
Clínica de Todos os
Santos
5 Dentarmed
7 Dentaurum
9 Dentsply Sirona
2 OralMED
4 White Clinic
6 DentalPro
8 Allianz Dental
Malo Clinic
10
Key Note:

42
4.2.1 VitalDent
▪ VitalDent present solutions in dental health so that
our patients enjoy a better quality of life
▪ VitalDent offers a totally personalized service through
our App and the VitalDent Care platform, because
our objective is to take care of the oral health of our
patients
▪ Advent International , one of the world's leading and
most experienced private equity firms, is the majority
shareholder of VitalDent
Treatments provided by VitalDent
➢ Inplantology
➢ Dentures
➢ Orthodontics
➢ Odontology
➢ Dental Aesthetics
Founded in: 1989
HQ: Pozuelo de Alarcón,
Madrid, Spain
Type: Private
Revenue: $1Bn (est. 2022)
Website: www.vitaldent.com
VitalDent Clinics in Spain
Girona Ourense
badajoz alava
Santa Cruz of Tenerife Cantabria
Alicante Gipuzkoa
Malaga Huesca
Pontevedra Saragossa
33+ years
of
experience
+2,000
experience
d dentists
+360
clinics in
Spain
+7,500,000
patients
treated
VitalDent company overview
Recent News/Press releases
April 2023, Vitaldent has received the Seal for the
Best Service of the Year in dental clinics
March 2023, Vitaldent estrena nuevas
instalaciones en Guadalajara
August 2022, Vitaldent awarded at the IX
Edition of the A Tu Salud de la Razón Awards

43
4.2.1 VitalDent (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Merger - Nov, 2022
▪ RC Celta and Vitaldent , the first dental operator in Spain and
Italy, have signed an agreement that makes this entity the official
dental clinic of the celestial club
▪ The agreement will be in force during the 2020/2021 season and
includes a program of check-ups and discounts on oral health
treatments that players and club members can benefit from.
Merger - Feb, 2022
▪ Envista Holdings Corporation its partnership agreement with the
Vitaldent Group, a leading Spanish Dental Service Organization
(DSO)
▪ Vitaldent is dedicated to providing quality, accessible odontology
to patients using the most advanced technology, best treatment,
and professional care
▪ This agreement positions Envista as the preferred supplier of
implants (Nobel Biocare) and clear aligners (Spark)
Latest Deals - Mergers and Acquisitions

44
63.3
70.3 70.9
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
4.2.2 Malo Clinic (continued)
Revenues ($Bn), 2020-2030
▪ According to Malo Clinic's 2021 financial
report, the company had sales of $21.2 Mn
in 2021
▪ Revenue generated by Malo Clinic in 2020
reflects the company's continued growth
and success in the healthcare industry
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative

45
4.2.2 Malo Clinic
▪ It is an operator of a surgical technique designed to
operate acute oral surgeries. It has a number of
clinics strategically located to serve its clients from
North to South, including Madeira Island
▪ It provides and is pioneer in the All-on-4® Treatment
Concept
▪ More than 160,000 patients were treated in its clinics,
of which more than 20,000 came from 50 different
countries
Complementary services offered by Malo Clinic
➢ General Anesthesia and Conscious Sedation
➢ Pharmacy
➢ Imageology
➢ Medical exams
➢ Fixed prosthesis laboratory
➢ Professional Training and Consultancy
Founded in: 1995
HQ: Lisbon, Portugal
Type: Private
Revenue: $15.8 Mn (2021)
Website:www.maloclinics.com
Assessment Consultation Emergencies
Implantology Oral Surgery
Periodontology Prosthodontics
Endodontics Orthodontics
Pediatric Dentistry Oral Medicine
Orofacial Harmonization Functional Jaw Orthopaedics
Oral Hygiene Myofunctional Therapy
Dental Specialities Recent Activity / Press Coverage
“Innovator of the Year 2011” awarded by the Mediazone Group in
the context of the publication “Hong Kong Most Valuable
Companies”
Award “Professor Armando Simões dos Santos” – 2008 & 2006
Winner of the Mercúrio Award in the Services category
2012/2013

46
Major Partnership
Partnerships Ecosystem
▪ MALO CLINIC and NOBEL BIOCARE have joined forces in the
commitment to innovation in Dentistry through the most
advanced solutions
▪ Nobel Biocare is the exclusive dental implant partner of MALO
CLINIC
▪ The partnership with KULZER is based on a conscious
choice to work side by side with partners of excellence
▪ As one of the world’s leading dental companies and part of
the Mitsui Chemicals Group, Kulzer has been a reliable
partner for all dental professionals for more than 80 years

47
Company Name Type
Amount /
Duration
Year Key Pointers
Partnership -
November
2021
▪ Moi Composites has established a partnership agreement with
Malo Clinic, renowned dental experts based in Portugal
▪ The partnership includes clinical trial cases using Hi-Fiber
products, a line of efficient, effective, metal-free dental
reinforcement structures designed and 3D printed from advanced
materials and moi Composites’ exclusive, patented technology
Continuous Fiber Manufacturing (CFM)
Acquisition - May 2019
▪ Atena Equity Partners is a private equity firm focused on
acquiring and investing in lower middle-market Portuguese
companies
▪ Private equity firm Atena Equity Partners acquired healthcare
services company Malo Clinic
▪ This is Atena Equity Partners’ 1st transaction in the Healthcare
Services sector

48
63.3
70.3 70.9
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
▪ According to Malo Clinic's 2021 financial
report, the company had sales of $21.2 Mn
in 2021
▪ Revenue generated by Malo Clinic in 2020
reflects the company's continued growth
and success in the healthcare industry
1 2 3 4
Illustrative

49
4.2.3 Company 2
Founded in:
HQ:
Type:
Revenue:
Website:
Solutions offered by Company
Drugs Indications
Drugs for Cancer Recent Activity / Press Coverage
Illustrative

50
4.2.3 Company 3 (continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem

51
Company Name Type
Amount /
Duration
Year Key Pointers

52
xx xx xx
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
▪ Please be aware that this sample report is
report
▪ In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
interest
1 2 3 4

5. Reimbursement Scenario

54
5.1 Reimbursement Regulation
The reimbursement scenario in the Portugal Dental Care Market is complex and
can vary depending on the specific treatment, setting of care, and insurance
coverage. Here are some key points to consider:
▪ Medicare:
o Medicare is a federal health insurance program for people aged 65 and
older, as well as people with certain disabilities or health conditions
o Medicare covers many cancer treatments, including chemotherapy,
radiation therapy, and some immunotherapies
o However, coverage can be subject to strict guidelines and restrictions,
such as the requirement for prior authorization
▪ Medicaid:
o Medicaid is a joint federal-state program that provides health insurance
for people with low incomes
o Medicaid coverage for cancer treatments can vary by state, and may be
subject to limits on the amount and type of treatment covered
▪ Private Insurance:
o Private insurance coverage for cancer treatments can also vary widely
depending on the insurer and the specific policy
o Some policies may have high out-of-pocket costs, such as deductibles
and co-pays, while others may have more comprehensive coverage
Medicare and Medicaid together provide
health insurance coverage for more than
4 in 10 Americans
Medicare
17%
Medicaid
and CHIP
21%
Employer-Sponsored
49%
Other Private
3%
Other Public
1%
Uninsured
9%
Health Insurance Coverage, 2022
Illustrative

55
5.1 Reimbursement Regulation (continued)
▪ Affordable Care Act:
o Affordable Care Act (ACA) includes provisions to help improve access to cancer treatments by requiring insurers to cover
certain preventive services, including cancer screenings, without co-pays or deductibles
o It also includes protections for people with pre-existing conditions, such as cancer
▪ Reimbursement for New Treatments:
o Reimbursement for new cancer treatments can be a complex and lengthy process, as insurers and government programs
often require evidence of safety and effectiveness before providing coverage
o This can create challenges for companies developing and marketing new treatments
▪ Value-Based Care:
o There is a growing trend towards value-based care, which aims to improve outcomes and lower costs by focusing on the
value of treatments rather than simply the volume of treatments
o Value-based care models can include payment models that tie reimbursement to outcomes or performance metrics
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative

56
5.1 Reimbursement Regulation (continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
 Public healthcare coverage is provided by the government and includes programs like
Medicare and Medicaid
 Medicare is a federal program that provides healthcare coverage to individuals who
are 65 years of age or older, as well as certain younger people with disabilities
 Medicaid is a joint federal-state program that provides healthcare coverage to
individuals with low income and limited resources
▪ Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care 38.9%
37.1%
35.6%
32.5%
31.5%
44.0%
46.0%
47.7%
51.0%
51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx xx xx xx xx
2012 2013 2014 2015 2016
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative

57
5.2 Reimbursement Process for Dental Care
The reimbursement process in the US healthcare system can be complex and can vary depending on the type of healthcare service,
the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪ Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪ Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the
service provided
▪ Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for
reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential
errors or fraud
▪ Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service
provided, based on the negotiated payment rates or fee schedule
▪ Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost
of the service, such as deductibles, co-payments, or co-insurance
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative

58
5.3 Reimbursement Process for Dental Care
The reimbursement process in the US healthcare system can be complex
and can vary depending on the type of healthcare service, the healthcare
provider, and the insurance coverage. Here are the general steps involved
in the reimbursement process:
▪ Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪ Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪ Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪ Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
FDA
Private Payers Public Payers
Health Technology Assessment
Payment
Coverage
Coding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 3
2
Illustrative

59
5.4 Reimbursement Process - Medicare
Medicare
Population Covered
▪ 100% population is covered under this scheme
▪ Citizen’s contribute to this scheme which then earns an interest. There is Basic Healthcare Sum (BHS) cap which limits the maximum contribution to an
individuals Medicare account
Provider Restrictions/
Selection
Services can be claimed from Medicare-approved institutions only (14 public hospitals, 10 private hospitals, 7 public community centers, 1 private community
center and over 100 surgery centers, dialysis centers, colonoscopy centers and screening centers)
Services Covered
▪ Medicines under SDL and MAF Plus can be bought from the money saved in this account
▪ Money can be also be claimed for antiretroviral drugs for HIV, Desferrioxamine drug for treatment of thalassemia and immuno-suppressant drugs for organ
transplant
▪ Money from this account can be used to pay Medishield premiums and Integrated Shield Plan premiums, subject to withdrawal limits
▪ Patients above 65 years of age can claim under Flexi-Medicare and further reduce their out-of-pocket expenses by using up to $200 per patient per year from
their Medicare account
▪ Excluded: Traditional drugs such as Herbal and Ayurveda cannot be claimed from Medicare account; Drugs used for cosmetic purposes such as slimming pills
and hair loss pills cannot be claimed from this account
Level of Coverage/ Assurance
▪ Approved chronic conditions and vaccinations, health screenings as outpatient treatments can be paid with Medicare up to $500 per account per year, however
a cash copayment of 15% is applicable
▪ Inpatient hospitalization, up to $450 per day + surgical limits according to Table of Surgical Procedures
▪ Approved day surgeries up to $300 per day + surgical limits according to Table of Surgical Procedures
▪ Outpatient scans/ diagnostics for cancer up to $600 per year per patient, and up to $300 for other medical conditions
▪ Chemotherapy (includes analgesic medication and suppressive treatments such as neuroendocrine and nuclear medicine treatments) up to $1,200 per month
per patient
▪ Renal dialysis up to $450 per patient per month
▪ Other treatments are also approved with various sub-limits for withdrawal
Mechanism of Coverage
▪ DRG with Activity Based Funding for public providers
▪ Block funding with DRG for providers not covered under ABF
Financial Feasibility ▪ The Basic Healthcare sum has been increased by more than 4.4% in 2017 on account of increasing costs of healthcare. This is an individual account
Illustrative

60
5.5 Reimbursement Process - Medicaid
Medicaid
Population Covered
▪ 38% population is covered under this scheme
▪ Medicare covers individuals who are aged 65 and older, as well as those with certain disabilities or end-stage renal disease
Provider Restrictions/
Selection
Services can be claimed from Medicaid-approved institutions only (14 public hospitals, 10 private hospitals, 7 public community centers, 1 private community
center and over 100 surgery centers, dialysis centers, colonoscopy centers and screening centers)
Services Covered
▪ Medicines under SDL and MAF Plus can be bought from the money saved in this account
▪ Money can be also be claimed for antiretroviral drugs for HIV, Desferrioxamine drug for treatment of thalassemia and immuno-suppressant drugs for organ
transplant
▪ Money from this account can be used to pay Medishield premiums and Integrated Shield Plan premiums, subject to withdrawal limits
▪ Patients above 65 years of age can claim under Flexi-Medicaid and further reduce their out-of-pocket expenses by using up to $200 per patient per year from
their Medicaid account
▪ Excluded: Traditional drugs such as Herbal and Ayurveda cannot be claimed from Medicaid account; Drugs used for cosmetic purposes such as slimming pills
and hair loss pills cannot be claimed from this account
Level of Coverage/ Assurance
▪ Approved chronic conditions and vaccinations, health screenings as outpatient treatments can be paid with Medicaid up to $500 per account per year, however
a cash copayment of 15% is applicable
▪ Inpatient hospitalization, up to $450 per day + surgical limits according to Table of Surgical Procedures
▪ Approved day surgeries up to $300 per day + surgical limits according to Table of Surgical Procedures
▪ Outpatient scans/ diagnostics for cancer up to $600 per year per patient, and up to $300 for other medical conditions
▪ Chemotherapy (includes analgesic medication and suppressive treatments such as neuroendocrine and nuclear medicine treatments) up to $1,200 per month
per patient
▪ Renal dialysis up to $450 per patient per month
▪ Other treatments are also approved with various sub-limits for withdrawal
Mechanism of Coverage
▪ DRG with Activity Based Funding for public providers
▪ Block funding with DRG for providers not covered under ABF
Financial Feasibility ▪ The Basic Healthcare sum has been increased by more than 4.4% in 2017 on account of increasing costs of healthcare. This is an individual account
Illustrative

6. Methodology & Scope

Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

Analysis Methodology
Our Analysis Methodology involves three critical stages:
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Market Data Analysis
& Statistical Model
Interpretation &
Presentation
Secondary
Research
Proprietary
Database
Data
Collection
Primary
Research

Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

2022
2023-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (3 to 5 working days)
with purchase. We will provide you with data
that is currently not a part of our scope as a
part of customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
www.insights10.com
Lifesciences Market
Research Reports you
can trust

www.insights10.com
A large database of over 30,000 syndicated
market research reports in Healthcare Services
and healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Get actionable insights to
take informed business
decisions

Our qualitative, acute, and result-oriented market
research reports provide a comprehensive
understanding of the business scenario and the
latest trends related to the life sciences market
Elevate your business plans
with in-depth market analysis
and industry intelligence
www.insights10.com

Whether you are looking to expand into new
areas, develop new products, or take advantage
of new opportunities we have reports to help you
accelerate and improve your plans by identifying
unique growth prospects.
Gain a competitive edge with
Insights10's customized
healthcare research solutions
www.insights10.com

Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Healthcare Services
(Diseases & Drugs)
Digital
Health
Medical
Devices
across various categories
Market Research Reports

FEATURED REPORTS FREE SAMPLE REPORTS
TRENDING TOPICS

1200+
Reports
Published
Annually
30000+
Life science
Market Research
Reports
22000+
Country
Specific
Reports
2000+
Rare & orphan
Disease
Reports
What makes us different?

Market Overview
Growth Drivers &
Growth Restraints
Market Segmentation
Market Share Factors Driving Future Growth
Reimbursement Scenario
Policy & Regulatory
Landscape
Key Company Profiles
Epidemiology &
Disease type
Competitive Landscape
insights on
which our
reports are
based
1
2
3
4
5
6
10
9
8
7
Table of Contents

Subscription
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database
Service
Primary
Research
Customized
Reports
Market Research
Reports
Our Services

Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis

Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players

What kind of data is presented
in our reports?
Our reports present data, which is:
The report is
prepared using a
proven methodology
and insightful
research
Reliable
The data is prepared
by a team of highly
qualified &
experienced research
analysts & vetted by
our local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything
you would need to
know about the
market including
market size,
competitive analysis
& much more
Comprehensive
You do not have to
be a market expert
to understand what
really is happening
on the market and
how it works
Easy to read

“The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market.
We at Insights10 are building the future of market
research and are committed to providing our clients with
the right intelligence and insights to make business
decisions quickly and efficiently.
Insighs10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working
with some of the best organizations in the world,
generating insights that provides substantial competitive
advantage.”
Dr. Purav Gandhi
Founder & CEO

Purav is a physician and an entrepreneur
with 12+ years of experience in Healthcare
& Life Sciences industry spanning across
strategy, market access, health informatics
and RWE, digital health, analytics and data
science. Purav studied medicine from
Gujarat University and also completed his
MBA from IIM-Kozhikode. Purav started
his career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of experience
in management consulting in the
Life Sciences sector, and has
worked with diverse multinational
firms in the US, India, Middle East
and APAC regions. His primary
area of interest is Customer and
Market Strategy, Market Access,
and Digital Health with special
focus on emerging markets like
Africa, Middle East and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Leadership Team
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research & marketing
professional with a progressive
experience of over 20 years in Life
Sciences, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across diff.
markets (America, Europe, Africa, APAC
and Middle East). Her areas of expertise
include: Indentifying emerging trends in life
sciences industry, Competitor landscape
assessment, Disease opportunity
assessments etc. She is a pro in secondary
and primary research with a deep domain
expertise in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?

www.insights10.com
Thank you
We truly appreciate your business and
look forward to serving you.

Portugal Dental Care Market Analysis Sample Report

Recommended

Recommended

More Related Content

Similar to Portugal Dental Care Market Analysis Sample Report

Similar to Portugal Dental Care Market Analysis Sample Report (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

Portugal Dental Care Market Analysis Sample Report